New York State Common Retirement Fund
FTH

New York State Common Retirement Fund’s Faeth Therapeutics FTH Stock Holding History

New York State Common Retirement Fund’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8
Closed – – 3431
2022
Q2 		$0 Sell
8
-267
-97% -$10K ﹤0.01% 3534
2022
Q1 		$13K Hold
275
– – ﹤0.01% 3307
2021
Q4 		$32K Buy
275
+4
+1% +$598 ﹤0.01% 3275
2021
Q3 		$57K Buy
271
+1
+0.4% +$182 ﹤0.01% 3229
2021
Q2 		$53K Buy
270
+73
+37% +$18K ﹤0.01% 3257
2021
Q1 		$57K Buy
+197
New +$65.9K ﹤0.01% 3189

Other funds holding FTH

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

New York State Common Retirement Fund's FTH Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Faeth Therapeutics (FTH) in Q3 2022, closing a stake of 8 shares.

New York State Common Retirement Fund first reported a position in FTH in Q1 2021 and held it in 6 quarters. The position peaked at $57K in Q3 2021. 30 funds tracked by Wall St. Rank hold FTH as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Faeth Therapeutics position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 8 Faeth Therapeutics shares in Q3 2022.
  • New York State Common Retirement Fund first reported a position in Faeth Therapeutics in Q1 2021 and held it in 6 quarters.
  • New York State Common Retirement Fund's Faeth Therapeutics position peaked at $57K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.